BIPHASIC EFFECT OF SNP ON OPOSSUM ESOPHAGEAL LONGITUDINAL MUSCLE - INVOLVEMENT OF CGMP AND EICOSANOIDS

Citation
Jk. Saha et al., BIPHASIC EFFECT OF SNP ON OPOSSUM ESOPHAGEAL LONGITUDINAL MUSCLE - INVOLVEMENT OF CGMP AND EICOSANOIDS, The American journal of physiology, 265(2), 1993, pp. 70000403-70000407
Citations number
21
Categorie Soggetti
Physiology
ISSN journal
00029513
Volume
265
Issue
2
Year of publication
1993
Part
1
Pages
70000403 - 70000407
Database
ISI
SICI code
0002-9513(1993)265:2<70000403:BEOSOO>2.0.ZU;2-N
Abstract
Effects of nitric oxide (NO)-containing compounds on opossum esophagea l longitudinal smooth muscle in vitro were examined. Sodium nitropruss ide (SNP) and authentic NO produced a biphasic concentration-dependent relaxation-contraction sequence in the esophageal longitudinal muscle (ELM) but only a concentration-dependent relaxation of the lower esop hageal sphincter (LES) and no effect in the esophageal circular muscle . A cell membrane-permeable analogue of guanosine 3',5'-cyclic monopho sphate (cGMP), 8-bromoguanosine 3',5'-cyclic monophosphate (8-BrcGMP) also produced relaxation-contraction sequence in the ELM and relaxatio n of the LES. The guanylate cyclase inhibitors methylene blue (MB) and LY-83583 increased resting tone and had no significant effect on SNP- induced relaxation of ELM. However, they abolished the SNP-and NO-indu ced contraction of ELM. The cyclooxygenase inhibitor indomethacin had no effect on ELM relaxation and abolished the contractions due to SNP, NO, and 8-BrcGMP. These studies show that in the ELM 1) SNP, authenti c NO, and 8-BrcGMP cause a biphasic relaxation-contraction sequence; 2 ) MB and LY-83583 blocked contraction but not the relaxation associate d with SNP and NO; and 3) indomethacin blocked contractions but not th e relaxation due to SNP, NO, and 8-BrcGMP. These results suggest that in the ELM, NO donors exert an inhibitory action that is largely cGMP independent and an excitatory action via a cGMP-dependent pathway invo lving endogenous eicosanoids of the cyclooxygenase pathway.